Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Authors:
- Vanessa KulemannVKVanessa Kulemann
- Wolfgang SchimaWSWolfgang Schima
- Dietmar TamandlDTDietmar Tamandl
- Klaus KaczirekKKKlaus Kaczirek
- Thomas GruenbergerTGThomas Gruenberger
- Friedrich WrbaFWFriedrich Wrba
- Michael WeberMWMichael Weber
- Ahmed Ba-SsalamahABAhmed Ba-Ssalamah
- 1 August 2011
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 79 (2) , e1-e6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Magnetic Resonance Imaging of Liver Metastases: Experimental Comparison of Anionic and Conventional Superparamagnetic Iron Oxide Particles With a Hepatobiliary Contrast Medium During Dynamic and Uptake PhasesInvestigative Radiology, 2008
- Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel ImagingInvestigative Radiology, 2008
- Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasesBritish Journal of Surgery, 2007
- Comparison of Multiphase CT, FDG-PET and Intra-Operative Ultrasound in Patients with Colorectal Liver Metastases Selected for SurgeryAnnals of Surgical Oncology, 2006
- Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal MetastasesJournal of Clinical Oncology, 2006
- Superparamagnetic Iron Oxide-Enhanced Liver Magnetic Resonance ImagingInvestigative Radiology, 2006
- New MR techniques for the detection of liver metastasesCancer Imaging, 2006
- Liver metastases of colorectal cancer: US, CT or MR?Cancer Imaging, 2005
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004
- Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver ResectabilityAnnals of Surgical Oncology, 2001